Chimeric Antigen Receptor T-Cell Therapy in Dialysis-Dependent Patients With Multiple Myeloma: Insights From a 5-Case Series
Chimeric antigen receptor (CAR) T-cell therapy has emerged as a transformative treatment for multiple hematologic malignancies, including multiple myeloma. However, patients with advanced chronic kidney disease, particularly those who are dialysis-dependent, have generally been excluded from clinica...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2025-12-01
|
| Seri Bilgileri: | Kidney Medicine |
| Konular: | |
| Online Erişim: | http://www.sciencedirect.com/science/article/pii/S2590059525001773 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|